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Original Article
The objective of this study was to validate the defining characteristics for the nursing diagnosis of 
Fatigue in adult oncological patients. It is a cross-sectional, descriptive study with a quantitative 
perspective, and its type is diagnostic content validation. Data collection was carried out in 
a University Hospital. The sample was made up of 35 expert nurses. The instrument used 
was subdivided into four parts. The data was analyzed by descriptive statistics. 15 defining 
characteristics were identified, considered secondary indicators. With an average weighting of 
less than 0.50, four defining characteristics were excluded. The defining characteristic Impaired 
social interaction, added to those described by NANDA-I after review of the literature, was 
validated with a weighted average of 0.71. It was concluded that the subjectivity of the defining 
characteristics and the difficulty nurses have in recognizing them influence the identification of 
this diagnosis.
Descriptors: Validation Studies; Oncologic Nursing; Nursing Diagnosis; Fatigue.
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Validação das características definidoras do diagnóstico de Enfermagem: 
fadiga no paciente oncológico
O objetivo deste estudo foi validar as características definidoras do diagnóstico de Enfermagem, 
fadiga, em pacientes adultos oncológicos. Trata-se de estudo transversal e descritivo, em 
perspectiva quantitativa, do tipo validação de conteúdo diagnóstico. A coleta de dados foi 
realizada em um hospital universitário. Fizeram parte da amostra 35 enfermeiros peritos. 
Utilizou-se um instrumento subdividido em quatro partes. Os dados foram analisados por 
estatística descritiva. Identificaram-se 15 características definidoras, consideradas indicadores 
secundários. Com média ponderada inferior a 0,50, foram excluídas quatro características 
definidoras. A característica definidora Interação Social Prejudicada, acrescentada às descritas 
pela NANDA-I, após revisão da literatura, foi validada com média ponderada de 0,71. Concluiu-
se que a subjetividade das características definidoras do diagnóstico de Enfermagem, fadiga, e a 
dificuldade dos enfermeiros em reconhecê-las, influenciam na identificação desse diagnóstico.
Descritores: Estudos de Validação; Enfermagem Oncológica; Diagnóstico de Enfermagem; Fadiga.
Validación  de las características definidoras del diagnóstico de enfermería 
Fatiga, en pacientes oncológicos
Este estudio tiene como objetivo validar las características definidoras del diagnóstico de 
enfermería fatiga en pacientes adultos oncológicos. Se trata de un estudio transversal y 
descriptivo, en una perspectiva cuantitativa, del tipo validación de contenido diagnóstico. 
La recolección de datos fue realizada en un Hospital Universitario. Compusieron la muestra 
35 enfermeros peritos. Para la recolección de datos, se utilizó un instrumento subdividido 
en cuatro partes. Los datos fueron analizados por estadística descriptiva. Se añadió las 
características definidoras Interacción Social Perjudicada. No se encontró principales 
indicadores. Fueron identificados 15 características definidoras como indicadores secundarios. 
Con media ponderada inferior a 0.50, se excluyeron cuatro CD’s. La característica definidora 
Interacción Social Perjudicada, añadido a los descritos por la NANDA-I después de la revisión 
de la literatura, fue validada con media ponderada de 0.71. Se concluyó que la subjetividad 
de las características definidoras del diagnóstico de enfermería fatiga y la dificultad de los 
profesionales en reconocerlos influenció en la identificación de este diagnóstico.
Descriptores: Estudios de Validación; Enfermería Oncológica; Diagnóstico de Enfermería; 
Fadiga.
Introduction
In the care of oncological patients, the establishment 
of accurate Nursing Diagnoses (ND) can contribute to 
improvement in the patient’s quality of life. Nursing 
actions grounded in NDs are directed at real problems 
experienced by this population. 
 Many NDs have considered the problems experienced 
by oncological patients during the different phases of their 
illness and types of treatment. One ND which reflects a 
symptom caused by cancer and/or oncological treatment, 
however, is fatigue. If not diagnosed appropriately fatigue 
can debilitate the oncological patient, interfere with 
treatment and impair quality of life. 
Fatigue affects from 70% to 100% of patients who 
receive chemotherapy drugs, radiotherapy, or transplant 
of bone marrow or peripheral stem cells and biological 
response modifiers(1). It is the most prevalent and longest-
lasting symptom in terminally-ill patients, being reported 
by about 80% of patients during the course of the illness, 
with the prevalence varying between 75% and 99% in 
patients with advanced disease receiving palliative care, 
becoming more intense as death approaches.(2).
Fatigue’s complexity is considered in the ND, as it 
includes a group of Defining Characteristics (DCs) which 
must be present for the diagnosis to be established. The 
ND ‘Fatigue’ is included in the diagnostic terminology 
proposed by Nanda International (NANDA-I)(3). The 
inclusion of this ND happened in NANDA’s Taxonomy I in 
1988 and, currently,  the ND Fatigue is presented with 
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the following definition “an overwhelming sustained sense 
of exhaustion and decreased capacity for physical and 
mental work at usual level”(3). This definition has shown 
itself to be suited to the fatigue experienced by oncological 
patients, principally those in palliative care situations. This 
definition highlights the dimension of temporality present 
in the concept, through the term ‘sustained’, which denotes 
the chronic nature of this symptom(2). 
Some studies have identified the ND of fatigue in 
the sample researched. Among these, one carried out in 
the chemotherapy outpatients department of a University 
Hospital stands out. It aimed to establish the Nursing 
Diagnoses prevalent in eleven patients with colorectal 
cancer. 23 NDs were identified based on basic human needs 
which were altered in this population, and the existence of 
the ND of Fatigue was established in three patients(4). 
Contrary to these results, a recent study undertaken 
in a University Hospital in South Brazil has shown that 
the ND of Fatigue was present in 0.9% of a sample of 
109 patients with cancer. However, the DCs of the ND of 
Fatigue were present in 15.9% of the medical records, 
described in the nurses’ daily routines. The authors 
remained in doubt as to whether  the DCs fitted the ND of 
Fatigue, as the nurses, despite identifying the DCs, did not 
establish the ND of Fatigue(5). 
It may be observed in a bibliographic review study that 
similarities were found between the DCs of the ND of Fatigue 
as found in NANDA-I and the description of fatigue in the 
Oncology Nursing literature. The DCs which were similar 
were: tired, lethargic or listless, an increase in physical 
complaints, disinterest in surroundings, introspection, 
decreased performance, verbalization of an unremitting and 
overwhelming lack of energy, increase in rest requirements; 
inability to restore energy even after sleep, lack of energy or 
inability to maintain usual levels of physical activity or routines 
and compromised concentration. No correspondence was 
found, however, with the following defining characteristics 
from NANDA: perceived need for additional energy to 
accomplish routine tasks, drowsy, compromised libido and 
feelings of guilt for not keeping up with responsibilities(6).
It is believed that the establishing of the ND of Fatigue 
in oncological patients may favor educational activities 
for the management of fatigue, and guide measures for 
its prevention. This study also proposes to highlight this 
diagnosis, clarifying the meaning of each DC.
Thus, the objective of this study was to validate the 
DCs of the ND of fatigue in oncological patients.
Methods
It is a cross-sectional descriptive study, in a 
quantitative perspective, of the Content Validation 
Diagnostics (CVD) type proposed by Fehring(7), which 
is based on obtaining the opinions of expert nurses 
concerning the degree to which specified characteristics 
are indicative of a specified diagnosis. In this validation 
model, the author suggests that a literature review 
should be done so as to provide theoretical support for 
the defining characteristics and, further, emphasizes 
that during this process there is the possibility that 
the defining characteristics might be added to the list 
established by NANDA-I(7). 
This research was carried out at the Clinical Hospital 
of Porto Alegre (CHPA) in the State of Rio Grande do 
Sul, Brazil. This institution has specific departments 
for the treatment of oncological patients, such as the 
Hematopoietic Stem Cell Transplant Unit, Chemotherapy 
and Radiotherapy, apart from the Clinical and Surgical 
Units, which also receive oncological patients at different 
stages of the illness.
In relation to the population, of the 123 nurses who 
worked in the units where data collection was undertaken, 
35 were selected as experts.
The criteria for the selection of the experts were 
adapted from the model proposed by Fehring(7). To be 
considered an expert, the nurses had to have at least five 
points in the criteria described in Figure 1. These criteria 
were developed especially for this study, so as to include 
non-management/-administrative nurses who provide 
care to oncological patients and who had experience with 
the terminology of NANDA-I.
Criteria Scoring
Have PhD or Master’s. 3
Have title of Specialist in Oncology Nursing, from the 
Brazilian Society of Oncology Nursing (BSNO). 3
Specialization or residency program in Oncology 
Nursing. 3
Use NANDA-I diagnostic terminology in clinical 
practice. 3
Minimum of one year’s clinical practice with 
oncological patients. 2
Research or articles published on NCS, ND or 
oncology. 2
Abstracts published on NCS, ND or oncology 1
Participation in courses or congresses referent to 
NCS, ND or oncology, minimum of 4 hours. 1
Figure 1 – Criteria used for selection of expert nurses in 
this study. Porto Alegre, Rio Grande do Sul, Brazil, 2010
It’s important to emphasize that, to participate in 
the study, the nurses accepted to respond to the data 
collection instrument. The handing-back of the instrument 
took place at a pre-arranged time, which varied from 24 
hours later to two weeks. 
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Experts who failed to return the filled-out questionnaire 
during the data collection period, or who returned it only 
partly-filled out, were excluded. 
The participants were invited by the researcher to 
participate in the study during periodical visits to the 
units. After acceptance, they received an instrument 
for data collection and agreed a date for returning it, 
according to each nurse’s availability for responding to the 
questionnaire.
Data related to the subjects was analyzed through 
descriptive statistics, using frequencies and averages. 
For analysis of the DCs, the researchers calculated a 
weighted average of the grades which the nurses had 
given to each defining characteristic, in line with the 
methodology suggested by Fehring(7), in which one 
considers the following values, referent to the Likert 
Scale: 1=0; 2=0.25; 3=0.50; 4=0.75; 5=1. This stage 
is part of the first of five steps suggested by Fehring(7) 
for analysis of the data. 
This being so, the content validation of 19 DCs 
described by NANDA-I, corresponding to the ND of Fatigue, 
was carried out. To these, one defining characteristic 
identified in the literature review was added: Impaired 
Social Interaction. 
The definition given for this characteristic is the 
following: compromising of the relations between members 
of a group or between groups. It is characterized by the 
refusal of invitations which lead the patient to interact 
with other individuals, and by inability to tolerate the 
stimulation associated with social interactions, even with 
members of the family or friends(8-9).
The second step, which is considered optional, 
uses the Delphi technique, with repeated rounds of 
questionnaires, so as to obtain a consensus of a group of 
expert nurses on the subject of DCs of the ND of Fatigue 
studied (this step was not used in this study). 
The third step involves calculating the weighted 
averages of the grades given to each of the DCs. In 
the fourth step, DCs with weighted averages inferior to 
0.50 are discarded. The excluded DCs were: disinterest 
in surroundings, lethargic, compromised concentration 
and listless.
In the fifth step, the DCs with averages of between 
0.79 and 0.50 are considered as secondary indicators; 
these are characteristics which offer secondary evidence 
supporting the diagnosis(10).  15 DCs were identified as 
secondary indicators.
Finally, those with a weighted average equal or 
superior to 0.80 are considered principal indicators, that 
is, characteristics which must be present to validate the 
diagnosis, affirming that the diagnosis actually exists(10). 
Primary indicators were not identified.
 Below, the total CVD score will be obtained through 
summing the individual scores and dividing them by the 
total number of DCs for the diagnosis, excluding those 
with a weighted average of ≤0.50(7).
All the ethical and legal aspects of research on 
human beings were considered, in line with Resolution 
nº196/96 of the Ministry of Health’s National Health 
Council(11), being approved by the Research Commission 
(COMPESQ) of the Rio Grande do Sul Federal University 
Nursing School (UFRGS) and by the Post-Graduate and 
Research Group of the Porto Alegre Clinical Hospital 
(GPPG/HCPA), under no 100026.  The participants who 
agreed to participate in the study signed the Terms of 
Free and Informed Consent.  
Results
35 expert nurses took part in the study, all being 
female and caring for oncological patients in the Clinical 
and Surgical Inpatient Units, the Chemotherapy and 
Radiotherapy Outpatient Units, and the Hemopoietic Stem 
Cell Transplant Unit, in the three work shifts (morning, 
afternoon and night). Table 1 describes the sample profile. 
In relation to the scoring, all the experts obtained a 
minimum of five points, according to the criteria already 
presented for their selection. It can be observed that 
the total score varied between 5 and 14 points, with an 
average of 7.3 points and a standard deviation of 2.5 
among the 35 experts in this study.  
Table 1 – Description of the sample profile, relating to 
academic qualifications, scientific production and clinical 
experience in years, (n=35)
Variables f %
Academic qualification
Degree 9 25.7
Specialist in Oncology Nursing and Specialist 
recognized by BSNO
8 22.8
Specialist in other areas 12 34.3
Master’s degree 6 17.1
Scientific production
Research, articles published on NCS, ND or 
oncology
4 11.4
Abstracts published on NCS, ND or oncology 3 8.6
Participation in courses on NCS 21 60
Clinical experience in years
1-5 9 25.7
6-10 6 17.1
11-15 6 17.1
16-20 4 11.4
21-25 8 22.8
26-30 2 5.7
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As far as secondary indicators are concerned, 15 
defining characteristics (weighted average <0.80 and 
>0.50) were identified as such, as shown in Table 2.
 All the experts confirmed that they had experience 
with the NANDA-I diagnostic terminology and a minimum 
of one year’s clinical experience of working with oncological 
patients, as per the requirements previously established 
for being an expert.
The experts with Master’s degrees formed 17.1% 
of the sample. Two of the experts were studying for 
Master’s degrees. 22.8% of the experts had undertaken 
the Oncology Nursing course. In the current scenario it 
may be observed that the activity of the nurse is growing, 
considering the improving of oncological treatment and 
the new proposals for treatment. 
Four experts – that is, 11.4% - were identified as 
having the title of Specialist in Oncology Nursing from 
the BSNO. The BSNO was founded in 1888 and describes 
itself as a not-for-profit organization. The title, bestowed 
by the BSNO, is acquired by title examination and a 
written exam(13). It should be emphasized that these 
experts had taken the Oncology Nursing specialization 
course. However, the majority of the experts (34.3%) 
described themselves as specialist in other areas, such 
as Public Health, Health Service Auditing, Intensive 
Therapy, and Health Service Administration. This 
information shows that these professionals’ specialized 
knowledge contributed to the validation of the DCs 
and ND for Fatigue, as the oncological patient ends 
up circulating through the different sectors with these 
professionals.
It may also be observed that the search for knowledge 
makes the specializations an alternative for professional 
improvement in a highly competitive market. Apart from 
that, it is necessary for nurses who are active in health 
services to seek scientific knowledge which supports care-
giving practice(14). 
Concerning the DCs, no principal indicators for this 
diagnosis (weighted average ≥0.80) were identified in 
the opinions of the experts. These indicators would be 
evidence that the ND of Fatigue is appropriate. This result 
may be attributed to the subjectivity which permeates the 
defining characteristics of this diagnosis(6), that is, most 
are based on the discourse of the patient herself.  This 
fact emphasizes the importance of a complete evaluation, 
including therapeutic listening, making it possible for 
people to express what they are feeling. An overload 
of tasks very often means that the nurse cannot give 
adequate attention to the patients – and because of this, 
some characteristics which are subjective are forgotten or 
unmentioned. 
Apart from this, the cut-off point (0.80) may 
not be appropriate for the evaluation of the principal 
indicators, being considered high for their validation. 
It is necessary to undertake studies which render the 
The four characteristics which were excluded are 
described in Table 3.
The defining characteristic Impaired Social 
Interaction, which was suggested following a literature 
review, was validated as a secondary indicator (weighted 
average 0.71). 
Discussion
The size of the sample seems not to have influenced 
the results, as the opinion of the experts was uniform. 
Although the majority of the validation studies use the 
model proposed by Fehring, there is no defined consensus 
about the criteria for selecting experts(12). It is important 
that these criteria should be appropriate to the sample 
studied, which is why they were adapted in this study. 
Table 2 – Weighted averages of the defining characteristics 
of the ND for Fatigue, identified as secondary indicators 
according to the judgment of the experts.
Defining Characteristics Weighted Average
Inability to maintain usual level of physical activity 0.79
Increase in physical complaints 0.74
Lack of energy 0.74
Inability to restore energy even after sleep 0.74
Inability to maintain usual routines 0.73
Introspection 0.73
Decreased performance 0.72
Perceived need for additional energy to accomplish 
routine tasks
0.70
Tired 0.69
Compromised libido 0.69
Verbalization of an unremitting lack of energy 0.66
Increase in rest requirements 0.65
Feelings of guilt for not keeping up with 
responsibilities
0.63
Drowsy 0.61
Verbalization of an overwhelming lack of energy 0.54
Table 3 – Weighted average of the defining characteristics 
of the ND for Fatigue which were excluded, according to 
the judgment of the experts
Defining Characteristics Weighted Average
Disinterest in surroundings 0.49
Lethargic 0.49
Compromised concentration 0.48
Listless 0.42
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cut-off point recommended by Fehring appropriate 
to the reality in Brazil. Another fact which may have 
contributed to this result is related to the academic 
qualification of the experts who did the validation. 
Although all the experts reported having experience 
with oncological patients, only 22.8% of the experts 
were specialists in oncology nursing. It was decided 
to include nurses with other specialities to show 
that these, even with their specific knowledge being 
from other areas, were experts, due to their clinical 
experience with oncological patients, as a result of 
their providing daily hands-on care to these patients in 
all phases of the illness. 
Of the DCs which were identified as secondary 
indicators, eight had a weighted average between 
0.70 and 0.79. The DC with the strongest indicator 
is Inability to maintain usual level of physical activity 
(0.79), which showed similarities with the DC Inability 
to maintain usual routines (0.73). Both represent the 
difficulty people have in carrying out activities of daily 
life: activities such as walking, taking exercise, cleaning 
the house, cooking and even eating can become 
highly challenging for patients with fatigue(15), directly 
influencing their quality of life. The DC Increase in 
physical complaints is frequently identified in patients 
with fatigue(16-17), but was not validated in healthy women 
living in a city in the Mid-West of the United States along 
with the DC Feelings of guilt for not keeping up with 
responsibilities(18), differently from the results of this 
research, which validate these DCs with the respective 
scores of 0.74 and 0.63.  
Tired (0.69) and Lack of energy (0.74) are closely-
linked defining characteristics. Both are frequently reported 
by patients with fatigue, being considered, as a result, 
synonymous. Fatigue related to cancer is described, by 
the patients, as extreme tiredness(19). 
The DC Decreased performance (0.72) is a subjective 
symptom related to the motivation or cognitive impairment 
which fatigue can cause(20). The DC Perceived need for 
additional energy to accomplish routine tasks (0.70) sheds 
light on the lack of energy of those who feel it, once they 
find themselves unable to continue their tasks which they 
had previously done. 
The alterations in sleep patterns of people stricken by 
neoplasias with fatigue are common. Patients with fatigue 
report feeling tired even after a night’s sleep(21). The DC 
Inability to restore energy even after sleep (0.74) and the 
DC Drowsy (0.61) clearly define this situation, making it 
an important element in the detection of fatigue. 
The DCs Verbalization of n unremitting lack of 
energy (0.66) and Verbalization of an overwhelming 
lack of energy (0.54) bring up the question of 
subjectivity, as they are DCs based in the patients’ 
reports. However, even with the verbalization of 
something as characteristic as lack of energy, fatigue is 
neither identified or evaluated appropriately by health 
care professionals(22).
The DCs Compromised Concentration (0.48), Listless 
(0.42), Disinterest in surroundings (0.49) and Lethargic 
(0.49) were excluded. Among these, in some studies(15,19,21), 
the DC Compromised concentration is mentioned as being 
frequent in patients with fatigue, but due to the fact of 
the patient being in hospital, this characteristic is not 
identified frequently, in the opinion of the experts. 
The suggested DC Impaired Social Interaction 
obtained a weighted average among the experts of 
0.71, being selected as a secondary indicator of the 
ND of fatigue in the oncological patient.  Some studies 
undertaken with patients in outpatient treatment have 
indicated the difficulty that patients with fatigue have in 
interacting socially, for example going to the mall, going 
to restaurants, playing with their children, staying with 
friends or just enjoying life at that moment(21,23).
The total CVD found was of 0.69. Of the DCs of the 
ND of Fatigue proposed by NANDA-I, along with the DC 
indicated in this study, 55% (11 DC’s) obtained a score 
above the total CVD, which indicates that the majority of 
the DCs are relevant for diagnosing the ND of Fatigue in 
the oncological patient(24).
Conclusions
Validating the ND of Fatigue in the oncological 
population was chosen because Fatigue is an adverse 
event which has affected these patients frequently, as well 
as being debilitating, influencing the oncological patient’s 
quality of life. Further, the lack of Brazilian studies on 
this subject may be related to the difficulty of identifying 
fatigue. This being so, the content validation of the 19 
defining characteristics belonging to NANDA-I, plus one 
characteristic identified in the literature review, was 
carried out. 
In the experts’ opinion, no principal indicators were 
identified, and 15 DCs were identified as secondary 
indicators. The total CVD score was 0.69, which shows 
that more than half of the defining characteristics of the 
ND of Fatigue obtained a score equal to or greater than 
this, demonstrating that the majority of the DCs of the ND 
of Fatigue are related to the oncological patient and are 
relevant to its identification. 
For continuity of this study, it is suggested that 
clinical validation of this diagnosis be carried out in 
oncological patients who have the same neoplasia and the 
same oncological treatment, as was also suggested by the 
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experts, as – according to them – the fatigue experienced 
by the patients can vary with the stage of treatment and, 
due to this, a more specific study is needed.
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